Making New Drugs With a Dose of Artificial Intelligence

Researchers at DeepMind, owned by Google’s parent company, and other companies are applying their powerful A.I. systems to drug discovery research.
The New York Times
By CADE METZ from NYT Technology https://nyti.ms/2WS7yaS